Care Pathway for Patients With Fabry's Disease (Fabry-PATH)

ConditionFabry Disease
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUniversity Hospital, Toulouse

About this trial

Fabry's disease is an X-linked disorder that manifests differently in men and women, leading to differences in healthcare pathways. In women, the disease is sometimes diagnosed through family screening despite the presence of symptoms (symptoms appear later than in men, and the phenotypic expression of the disease is sometimes more subtle). Conversely, in men, the presence of symptoms combined with abnormalities in medical examinations facilitates diagnosis. There is limited data on the differences in healthcare pathways between men and women, which could nevertheless impact diagnosis by identifying a profile of at-risk patients, and consequently, their management.

The goal of this present study is to describe the differences in care pathways between men and women with Fabry's disease, distinguishing entry via symptoms or family screening through a non-interventional study based on a questionnaire sent to patients and on the collection of medical data at the time of diagnosis.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Adult patient diagnosed with Fabry's disease

Disqualifiers

Minor patients

Trial population

Any adult patients with a Fabry's disease diagnosis

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • Self-questionnaire

    Other intervention

    Medical data of Fabry's disease

Treatment groups

200 Participants
are divided into 1 treatment group
Group A: Fabry's disease patients1 intervention

Trial outcomes

Primary outcomes

1

Diagnostic time in care pathways between men and women with Fabry's disease

The average diagnostic time, compared between men and women, and the diagnostic methods (entry point into the disease), compared according to sex.

Time frame
8 months
2

Comparison of diagnostic methods between men and women

Data collection at the point of entry into the disease: via symptoms or family screening

Time frame
8 months

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: